Randox recalls coronavirus test kits after safety concerns
Up to 750,000 unused testing kits to be recalled
Read More
Author: Lucy Parsons
Destiny Pharma’s novel antibiotic asset clears safety review
Independent Data Monitoring Committee recommended continuing Phase IIb study
Read More
Eli Lilly, Pieris collaborate on HER2-positive cancer clinical programme
Companies will focus on HER2-positive gastric cancer
Read More
Roche’s SMA treatment Evrysdi bags US approval
Drug cleared for use in SMA patients aged two months or older
Read More
Pfizer inks manufacturing deal with Gilead for COVID-19 med remdesivir
Pfizer becomes one of multiple external manufacturing organisations supporting scale-up of treatment
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
